Diagnostic development study demonstrates improved specificity in colorectal cancer screening populations, indicating refined noninvasive detection.
A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily with regard to specificity.
No takes yet. Share an insight, caveat, or question.
Imperiale et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: